Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology ProgramsBusiness Wire • 09/09/24
Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024Business Wire • 09/06/24
Xencor (XNCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 05/06/24
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical UpdateBusiness Wire • 02/20/24
Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?Zacks Investment Research • 02/19/24
Xencor (XNCR) Earnings Expected to Grow: What to Know Ahead of Q4 ReleaseZacks Investment Research • 02/15/24